Abstract
Journal of Case Reports in Medicine,2013,2,1,1-3.Published:April 2013Type:Case ReportAuthors:Marie Nguyen, and John R. Cohn Author(s) affiliations:Marie Nguyen1 and John R. Cohn2 Department of Medicine, University of Florida, Gainesville, FL 32610, USA. Division of Allergy and Immunology, Department of Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA. Abstract:Oral corticosteroids are first-line therapy for allergic bronchopulmonary aspergillosis (ABPA), however, itraconazole has been recognized as an adjunctive treatment. This paper describes the prolonged use of itraconazole in an asthmatic patient with a diagnosis of ABPA. This case report features a patient who showed benefit with a longer duration of itraconazole therapy without demonstrating adverse events related to treatment over nearly eight years. Prolonged treatment with itraconazole may serve as a corticosteroid sparing option for ABPA patients. Keywords:Allergic bronchopulmonary Aspergillosis; ItraconazoleView:PDF (94.39 KB) PDF Images Prolonged Role of Itraconazole in the Treatment of Allergic Bronchopulmonary Aspergillosis
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
